Department of Biomaterials Science (BK21 FOUR Program), Life and Industry Convergence Research Institute, Laboratory Animal Resources Center, College of Natural Resources & Life Science, Pusan National University, Miryang 50463, Republic of Korea.
College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
Int J Mol Sci. 2024 May 2;25(9):4964. doi: 10.3390/ijms25094964.
The impact of microplastics (MPs) on the metabolic functions of the liver is currently unclear and not completely understood. To investigate the effects of the administration of MPs on the hepatic metabolism of normal and obese mice, alterations in the lipid, glucose (Glu), and amino acid regulation pathways were analyzed in the liver and adipose tissues of C57BL/6Korl (wild type, WT) or C57BL/6-Lep/Korl mice (leptin knockout, Lep KO) orally administered polystyrene (PS) MPs for 9 weeks. Significant alterations in the lipid accumulation, adipogenesis, lipogenesis, and lipolysis pathways were detected in the liver tissue of MP-treated WT and Lep KO mice compared to the vehicle-treated group. These alterations in their liver tissues were accompanied by an upregulation of the serum lipid profile, as well as alterations in the adipogenesis, lipogenesis, and lipolysis pathways in the adipose tissues of MP-treated WT and Lep KO mice. Specifically, the level of leptin was increased in the adipose tissues of MP-treated WT mice without any change in their food intake. Also, MP-induced disruptions in the glycogenolysis, Glu transporter type 4 (GLUT4)-5' AMP-activated protein kinase (AMPK) signaling pathway, levels of lipid intermediates, and the insulin resistance of the liver tissues of WT and Lep KO mice were observed. Furthermore, the levels of seven endogenous metabolites were remarkably changed in the serum of WT and Lep KO mice after MP administrations. Finally, the impact of the MP administration observed in both types of mice was further verified in differentiated 3T3-L1 adipocytes and HepG2 cells. Thus, these results suggest that the oral administration of MPs for 9 weeks may be associated with the disruption of lipid, Glu, and amino acid metabolism in the liver tissue of obese WT and Lep KO mice.
微塑料 (MPs) 对肝脏代谢功能的影响目前尚不清楚,也不完全了解。为了研究 MPs 给药对正常和肥胖小鼠肝脏代谢的影响,分析了 C57BL/6Korl(野生型,WT)或 C57BL/6-Lep/Korl 小鼠(瘦素敲除,Lep KO)口服聚苯乙烯(PS) MPs 9 周后肝脏和脂肪组织中脂质、葡萄糖(Glu)和氨基酸调节途径的变化。与载体处理组相比,MP 处理的 WT 和 Lep KO 小鼠肝脏组织中脂质积累、脂肪生成、脂肪生成和脂肪分解途径发生显著改变。这些肝脏组织的变化伴随着血清脂质谱的上调,以及 MP 处理的 WT 和 Lep KO 小鼠脂肪组织中脂肪生成、脂肪生成和脂肪分解途径的改变。具体来说,MP 处理的 WT 小鼠脂肪组织中的瘦素水平升高,而其食物摄入量没有变化。此外,还观察到 MPs 诱导的 WT 和 Lep KO 小鼠肝脏组织中糖原分解、Glu 转运蛋白 4 (GLUT4)-5' AMP 激活蛋白激酶 (AMPK) 信号通路、脂质中间产物水平和胰岛素抵抗的破坏。此外,MP 给药后 WT 和 Lep KO 小鼠血清中的七种内源性代谢物水平发生显著变化。最后,在分化的 3T3-L1 脂肪细胞和 HepG2 细胞中进一步验证了两种类型小鼠中观察到的 MP 给药的影响。因此,这些结果表明,口服 MPs 给药 9 周可能与肥胖 WT 和 Lep KO 小鼠肝脏组织中脂质、Glu 和氨基酸代谢的破坏有关。